Key result
Cumulative metabolic syndrome score linked to ~5% greater cardiometabolic multimorbidity progression risk per unit.
Why the study?
Cardiometabolic multimorbidity leads to adverse health outcomes, but the impact of cumulative exposure and dynamic change patterns of metabolic syndrome score on its progression remains to be explored.
Is cumulative exposure and dynamic change in metabolic syndrome score associated with cardiometabolic multimorbidity progression in middle-aged and older Chinese adults?
Cohort (n=3,322)
Yes
Is cumulative exposure and dynamic change in metabolic syndrome score associated with cardiometabolic multimorbidity progression in middle-aged and older Chinese adults?
Effect estimate: OR 1.05 (95% CI 1.02-1.07)
p-value: p=<0.001
Cumulative exposure to metabolic syndrome is associated with progression to cardiometabolic multimorbidity, though this risk may be modified by physical activity.
Cumulative MetSS should not yet guide CMM risk management; leaves open its independent role beyond physical activity for prevention trials.**[[1]](https://pmc.ncbi.nlm.nih.gov/articles/PMC13112801/)[[2]](https://sciety.org/articles/activity/10.21203/rs.3.
Cardiometabolic multimorbidity (CMM) leads to adverse health outcomes. Based on data from the China Health and Retirement Longitudinal Study (CHARLS), we aimed to explore the cumulative exposure and dynamic change patterns of metabolic syndrome score (MetSS) with CMM progression among middle-aged and older Chinese adults. Age and sex specific MetSS was assessed according to equations which were developed for Chinese. K-means clustering analysis was used to classify MetSS changes, and cumulative MetSS (cuMetSS) was calculated as follows: (MetSS2012 + MetSS2015)/2 × time (2015 − 2012). The progression of CMM was defined starting with CMD-free, developing into first CMD (FCMD), further progressing into CMM. Logistic regression analyses and restricted cubic splines (RCS) were performed to evaluate the association of MetSS with CMM progression in 3 models. Subgroup and interaction analyses were subsequently undertaken to investigate the effect of physical activity on the associations of baseline MetSS, cuMetSS and MetSS change patterns with FCMD and CMM risk, respectively. A total of 3,322 participants were eligible for analysis, of whom 679 experienced FCMD and 101 progressed to CMM. The K-means method classified 4 clusters. Logistic analyses revealed that the risk of CMM both increased with baseline MetSS and cuMetSS increment in all 3 models. Baseline MetSS on continuous scale was not significantly associated with FCMD (all P > 0.05). Yet cuMetSS on continuous scale was significantly associated with increased risk of FCMD when adjusted age and gender (model 1: OR, 95% CI, P: 1.02, 1.01 to 1.03, 0.006), additionally adjusted education, marital status, residence, drinking status, smoking status, BMI and comorbidity (model 2: 1.02, 1.00 to 1.03, 0.008). Further additional adjustment for physical activity (model 3) yielded no statistical significance (P > 0.05). Further subgroup analyses suggested that significance was only noted in subgroups with inactive or vigorous physical activity. Our findings indicate that cumulative exposure and dynamic change patterns of MetSS were associated with FCMD and CMM, yet there is a modifiable effect of physical activity on the associations of cuMetSS and MetSS change patterns with FCMD risk.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Cardiometabolic multimorbidity (n=3,322). Cumulative metabolic syndrome score (cuMetSS) vs. Lower cuMetSS was evaluated on Progression to cardiometabolic multimorbidity (CMM) (OR 1.05, 95% CI 1.02-1.07, p=<0.001). Cumulative metabolic syndrome score significantly increased the risk of cardiometabolic multimorbidity progression (OR 1.05 per unit increase) in middle-aged and older Chinese adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: